Home A Simple HPLC Method for Monitoring Mycophenolic Acid and Its Glucuronidated Metabolite in Transplant Recipients
Article
Licensed
Unlicensed Requires Authentication

A Simple HPLC Method for Monitoring Mycophenolic Acid and Its Glucuronidated Metabolite in Transplant Recipients

  • Gernot Seebacher , Günter Weigel , Ernst Wolner , Robert Mallinger , Michael Grimm , Günter Laufer , Ibrahim El Menyawi , Andrea Griesmacher and Mathias M. Müller
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 37 Issue 4

Abstract

Mycophenolic acid (MPA) is nowadays in broad clinical use as a substitute for azathioprine. An immunoassay for MPA recently received approval for clinical applications. The high performance liquid chromatography (HPLC) assay for measuring MPA and its glucuronide conjugate (MPAG) we describe here is not only rapid and simple but also extremely sensitive at plasma levels obtained during standard immunosuppressive regimens. The determination of MPAG is possible without any change of the chromatographic conditions (detection wavelength of 214 nm, mobile phase: acetonitrile and 50 mmol/l o-phosphoric acid (50:50, V/V), run time: 15 min). The required equipment is a standard HPLC system including a simple UV-detector. Sample volume of 400 μl is required for both determinations. Detection limit is 0.25 μmol/l for MPA and 5 μmol/l for MPAG. Linearity is excellent for serial dilutions (0.5–25 μmol/l for MPA, 25–500 μmol/l for MPAG) and high accuracies favour the method described.

More than 2000 plasma samples tested for MPA in patients after heart transplantation within one year and more than 500 samples for MPAG underline the clinical applicability of this assay.

:
Published Online: 2005-06-01
Published in Print: 1999-04-01

Copyright (c)1999 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness
  2. Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review
  3. Improved Fluorescent PCR-Based Assay for Sizing CGG Repeats at the FRAXA Locus
  4. The Influence of Radiation and Chemotherapy-Related DNA Strand Breaks on Carcinogenesis: An Evaluation
  5. A Simple HPLC Method for Monitoring Mycophenolic Acid and Its Glucuronidated Metabolite in Transplant Recipients
  6. The Activities of Some Glycosaminoglycan-Degrading Enzymes in the Wall of the Umbilical Cord Artery and Their Alteration in Edema, Proteinuria, Hypertension (EPH)-Gestosis
  7. Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease
  8. Increased Serum Neopterin Concentrations in Patients with Alzheimer’s Disease
  9. Biomarkers of Bone Turnover and Bone Mineral Density in Hyperprolactinemic Amenorrheic Women
  10. Age Relationships and Sex Differences in Serum Levels of Pregnenolone and 17-Hydroxypregnenolone in Normal Subjects
  11. A Study of Hypermagnesaemia in a Hospital Population
  12. Multiple Regression Analysis of Interference Effects from a Hemoglobin-Based Oxygen Carrier Solution
  13. Serum Ionized Magnesium: Comparison of Results Obtained with Three Ion-Selective Analyzers
  14. Automated Prozone Effect Detection in Ferritin Homogeneous Immunoassays Using Neural Network Classifiers
  15. Recent Activities of EC4 in the Harmonization of Clinical Chemistry in the European Union
  16. Preventing Coronary Artery Disease. Cardioprotective Therapeutics in Practice. Edited by M. J. Kendall and R. C. Horton
  17. Will Medical Schools Remain what They Are? Medical Education in the Millennium. Edited by Brian Jolly and Lesley Rees
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1999.067/html
Scroll to top button